Izuma Nakayama

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Metastatic Colorectal Cancer

Helicobacter Pylori Infection

Monoclonal Antibody

Top Venues

Journal of cancer research and clinical oncology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Natsuko Okita, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinozaki
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology 150 (7) (2024)
Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Natsuko Okita, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinozaki
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology 150 (7) (2024)
Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Natsuko Okita, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinozaki
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology 150 (7) (2024)
Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Natsuko Okita, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinozaki
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology 150 (7) (2024)
Izuma Nakayama, Daisuke Takahari
The Role of Angiogenesis Targeted Therapies in Metastatic Advanced Gastric Cancer: A Narrative Review. Journal of clinical medicine 12 (9) (2023)
Keitaro Shimozaki, Izuma Nakayama, Toru Hirota, Kensei Yamaguchi
Current Strategy to Treat Immunogenic Gastrointestinal Cancers: Perspectives for a New Era. Cells 12 (7) (2023)
Koshiro Fukuda, Hiroki Osumi, Koichiro Yoshino, Izuma Nakayama, Shota Fukuoka, Mariko Ogura, Takeru Wakatsuki, Akira Ooki, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi, Eiji Shinozaki
Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors. BMC cancer 23 (1) (2023)
Izuma Nakayama, Daisuke Takahari
The Role of Angiogenesis Targeted Therapies in Metastatic Advanced Gastric Cancer: A Narrative Review. Journal of clinical medicine 12 (9) (2023)
Izuma Nakayama, Daisuke Takahari, Keitaro Shimozaki, Keisho Chin, Takeru Wakatsuki, Mariko Ogura, Akira Ooki, Daisaku Kamiimabeppu, Hiroki Osumi, Eiji Shinozaki, Kensei Yamaguchi
Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018. The oncologist 27 (6) (2022)
Izuma Nakayama, Eiji Shinozaki, Hiroshi Kawachi, Takashi Sasaki, Mayu Yunokawa, Junichi Tomomatsu, Takeshi Yuasa, Satoru Kitazono, Kokoro Kobayashi, Keiko Hayakawa, Arisa Ueki, Shunji Takahashi, Kensei Yamaguchi
Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice. Cancer medicine (2022)
Tetsuya Negoto, Minji Jo, Izuma Nakayama, Motohiro Morioka, Kengo Takeuchi, Hiroshi Kawachi, Toru Hirota
Profiling chromosomal-level variations in gastric malignancies. Cancer science 113 (11) (2022)
Izuma Nakayama, Daisuke Takahari, Takeru Wakatsuki, Hiroki Osumi, Keisho Chin, Mariko Ogura, Taro Sato, Takeshi Suzuki, Daisaku Kamiimabeppu, Akira Ooki, Mitsukuni Suenaga, Eiji Shinozaki, Kensei Yamaguchi
Single-institute comparison of the efficacy of systemic chemotherapy for oesophagogastric junction adenocarcinoma and stomach adenocarscinoma in a metastatic setting. ESMO open 5 (2) (2021)
Izuma Nakayama, Toru Hirota, Eiji Shinozaki
BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation. Cancers 12 (11) (2020)
Izuma Nakayama, Keisho Chin, Tomohiro Matsushima, Daisuke Takahari, Mariko Ogura, Eiji Shinozaki, Mitsukuni Suenaga, Masato Ozaka, Takeru Wakatsuki, Takashi Ichimura, Osumi Hiroki, Kensei Yamaguchi
Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis. International journal of clinical oncology 22 (6) (2017)